6 days ago
ZYME
AnalystsGregory RenzaGregory Renza's Stock Forecasts
AnalystsGregory Renza
Analyst Ranking
Top 3%
#136 out of 5539 analysts
Average Return
+19.94%
Win Rate
46%141 out of 304
Risk vs Reward
Poor
Good
Gregory Renza's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cidara Therapeutics IncCDTX | +1,088.30% | $18.63 | $221.38 | 2025-05-09 - 2026-01-06 | Buy |
Cidara Therapeutics IncCDTX | +864.38% | $22.88 | $220.65 | 2024-12-13 - 2025-12-12 | Buy |
Cidara Therapeutics IncCDTX | +811.78% | $24.28 | $221.38 | 2025-05-23 - 2026-01-06 | Buy |
Prometheus Biosciences IncRXDX | +603.13% | $27.52 | $193.50 | 2022-05-13 - 2023-04-18 | Buy |
Alpine Immune Sciences IncALPN | +428.30% | $12.19 | $64.40 | 2023-10-05 - 2024-04-11 | Buy |
Gregory Renza Analyst Color
Get additional color on Gregory Renza's coverage of popular stocks
6 days ago
RVMD
6 days ago
REGN
6 days ago
JAZZ
6 days ago
GILD
6 days ago
ONC
15 days ago
XNCR
2 months ago
JAZZ
2 months ago
RVMD
2 months ago
ZYME
2 months ago
ONC
2 months ago
JAZZ
3 months ago
NRIX
3 months ago
ZYME
3 months ago
ONC
3 months ago
ABVX
3 months ago
VRDN
3 months ago
RVMD
4 months ago
NRIX
5 months ago
RVMD
5 months ago
CGON
5 months ago
GILD
8 months ago
ONC
8 months ago
GILD
8 months ago
CGON
Gregory Renza's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Zymeworks IncZYME | 3 | Strong Buy | $34.00 | +34.23% | Maintains | 6 days ago |
Revolution Medicines IncRVMD | 5 | Strong Buy | $240.00 | +23.74% | Maintains | 6 days ago |
Regeneron Pharmaceuticals IncREGN | 9 | Strong Buy | $780.00 | +2.25% | Maintains | 6 days ago |
Mannkind CorpMNKD | 3 | Strong Buy | $5.00 | +59.74% | Maintains | 6 days ago |
Jazz Pharmaceuticals PLCJAZZ | 18 | Strong Buy | $286.00 | +31.95% | Maintains | 6 days ago |
Gilead Sciences IncGILD | 6 | Strong Buy | $158.00 | +5.03% | Maintains | 6 days ago |
Exelixis IncEXEL | 15 | Hold | $54.00 | -9.73% | Maintains | 6 days ago |
Beone Medicines LtdONC | 8 | Strong Buy | $420.00 | +19.86% | Maintains | 6 days ago |
Amgen IncAMGN | 23 | Hold | $380.00 | -9.00% | Maintains | 6 days ago |
Agios Pharmaceuticals IncAGIO | 12 | Strong Buy | $37.00 | +20.05% | Maintains | 6 days ago |
Xencor IncXNCR | 12 | Strong Buy | $29.00 | +15.81% | Reiterates | 15 days ago |
Abivax SaABVX | 4 | Strong Buy | $151.00 | +73.68% | Maintains | 21 days ago |
Viridian Therapeutics IncVRDN | 16 | Strong Buy | $39.00 | +113.11% | Maintains | 2 months ago |
Cg Oncology IncCGON | 9 | Strong Buy | $85.00 | +34.64% | Maintains | 2 months ago |
Ideaya Biosciences IncIDYA | 16 | Strong Buy | $59.00 | +63.62% | Maintains | 2 months ago |
Nurix Therapeutics IncNRIX | 14 | Strong Buy | $34.00 | +53.43% | Maintains | 3 months ago |
Nuvation Bio IncNUVB | 8 | Strong Buy | $13.00 | +165.31% | Maintains | 3 months ago |
Nuvalent IncNUVL | 2 | Hold | $124.00 | +0.03% | Downgrades | 4 months ago |
Fulcrum Therapeutics IncFULC | 6 | Hold | $4.00 | +6.67% | Downgrades | 4 months ago |
Perspective Therapeutics IncCATX | 7 | Strong Buy | $12.00 | +376.19% | Assumes | a year ago |
Bicycle Therapeutics PLCBCYC | 4 | Hold | $10.00 | +163.16% | Initiates Coverage On | a year ago |
Ascentage Pharma Group InternationalAAPG | 1 | Strong Buy | $51.00 | +233.12% | Initiates Coverage On | a year ago |
Cidara Therapeutics IncCDTX | 3 | Buy | $35.00 | N/A | Maintains | a year ago |
Acadia Pharmaceuticals IncACAD | 14 | Buy | $26.00 | N/A | Reiterates | a year ago |
Adc Therapeutics SaADCT | 12 | Buy | $8.00 | N/A | Reiterates | a year ago |
Inovio Pharmaceuticals IncINO | 11 | Hold | $5.00 | N/A | Reiterates | a year ago |
Spruce Biosciences IncSPRB | 13 | Hold | $0.50 | N/A | Maintains | a year ago |
Cormedix IncCRMD | 6 | Buy | $12.00 | N/A | Reiterates | 2 years ago |
Verastem IncVSTM | 10 | Buy | $14.00 | N/A | Maintains | 2 years ago |
Pacira Biosciences IncPCRX | 11 | Hold | $18.00 | N/A | Reiterates | 2 years ago |
Jasper Therapeutics IncJSPR | 4 | Buy | $48.00 | N/A | Maintains | 2 years ago |
Viracta Therapeutics IncVIRX | 8 | Buy | $2.00 | N/A | Maintains | 2 years ago |
Verrica Pharmaceuticals IncVRCA | 7 | Hold | $20.00 | N/A | Downgrades | 2 years ago |
Atyr Pharma IncATYR | 7 | Buy | $16.00 | N/A | Reiterates | 2 years ago |
Morphic Holding IncMORF | 7 | Hold | $57.00 | N/A | Reiterates | 2 years ago |
Alpine Immune Sciences IncALPN | 4 | Hold | $65.00 | N/A | Downgrades | 3 years ago |
Fusion Pharmaceuticals IncFUSN | 3 | Hold | $21.00 | N/A | Downgrades | 3 years ago |
Aptose Biosciences IncAPTOF | 7 | Buy | $540.00 | N/A | Maintains | 3 years ago |
Avalo Therapeutics IncAVTX | 4 | Hold | $180.00 | N/A | Downgrades | 3 years ago |
Bellus Health IncBLU | 8 | Hold | $14.75 | N/A | Reiterates | 3 years ago |
Prometheus Biosciences IncRXDX | 6 | Hold | $200.00 | N/A | Maintains | 3 years ago |
Seagen IncSGEN | 5 | Buy | $229.00 | N/A | Maintains | 4 years ago |
Global Blood Therapeutics IncGBT | 3 | Hold | $68.50 | N/A | Downgrades | 4 years ago |
Aprea Therapeutics IncAPRE | 5 | Hold | $80.00 | N/A | Maintains | 5 years ago |
Provention Bio IncPRVB | 2 | Hold | $10.00 | N/A | Downgrades | 6 years ago |
Iterum Therapeutics PLCITRMF | 3 | Hold | $30.00 | N/A | Downgrades | 6 years ago |
Portola Pharmaceuticals IncPTLA | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 6 years ago |
Arqule IncARQL | 1 | Hold | $20.00 | N/A | Downgrades | 7 years ago |
Gamida Cell LtdGMDAQ | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.